Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Cascone

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Nature Reviews. Clinical Oncology|July 1, 2026
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancerYago Garitaonaindia, Heather A Wakelee, Martin Reck, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2010
RETRACTED: Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitorsFloriana Morgillo, Elena D'Aiuto, Teresa Troiani, et al.
Cancer|February 21, 2013
Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapyVikas Bhardwaj, Tina Cascone, Maria Angelica Cortez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2023
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant TherapyAnnikka Weissferdt, Cheuk H Leung, Heather Lin, et al.
JTO Clinical and Research Reports|November 17, 2022
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant ChemotherapyApar Pataer, Annikka Weissferdt, Arlene M Correa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2021
Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant ChemotherapyApar Pataer, Annikka Weissferdt, Ara A Vaporciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancerLauren Averett Byers, Banibrata Sen, Babita Saigal, et al.
Journal of Translational Medicine|June 15, 2022
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021Elizabeth M Burton, Rodabe N Amaria, Tina Cascone, et al.
Journal of Cellular Physiology|April 3, 2008
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cellsTina Cascone, Maria Pia Morelli, Floriana Morgillo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2015
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastasesVivek Subbiah, Jenny Berry, Michael Roxas, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Nature Reviews. Clinical Oncology|July 1, 2026
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancerYago Garitaonaindia, Heather A Wakelee, Martin Reck, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2010
RETRACTED: Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitorsFloriana Morgillo, Elena D'Aiuto, Teresa Troiani, et al.
Cancer|February 21, 2013
Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapyVikas Bhardwaj, Tina Cascone, Maria Angelica Cortez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2023
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant TherapyAnnikka Weissferdt, Cheuk H Leung, Heather Lin, et al.
JTO Clinical and Research Reports|November 17, 2022
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant ChemotherapyApar Pataer, Annikka Weissferdt, Arlene M Correa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2021
Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant ChemotherapyApar Pataer, Annikka Weissferdt, Ara A Vaporciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancerLauren Averett Byers, Banibrata Sen, Babita Saigal, et al.
Journal of Translational Medicine|June 15, 2022
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021Elizabeth M Burton, Rodabe N Amaria, Tina Cascone, et al.
Journal of Cellular Physiology|April 3, 2008
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cellsTina Cascone, Maria Pia Morelli, Floriana Morgillo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2015
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastasesVivek Subbiah, Jenny Berry, Michael Roxas, et al.
Pageof 13